C

Abstract This chapter presents information on neonatal drugs that begin with C, including use, pharmacology, adverse effects, fetal and infant implications of maternal treatment, treatment, and supply of Cabergoline, Caffeine citrate, Calcium gluconate and other calcium salts, Captopril, Carbamazepine, Carglumic acid, Caspofungin, Cefalexin (Cephalexin—USAN and former BAN), Cefiderocol, Cefotaxime, Ceftaroline, Ceftazidime, Ceftazidime-avibactam, Ceftriaxone, Cefuroxime, Chloral hydrate, Chloramphenicol, Chloroquine, Chlorothiazide, Chlorphenamine (Chlorpheniramine—USAN and former BAN), Chlorpromazine, Ciprofloxacin, Citrulline, Clarithromycin, Clindamycin, Clobazam, Clonazepam, Clonidine, Co-amoxiclav (amoxicillin/clavulanic acid—rINN), Co-trimoxazole, and COVID-19 (SARS-CoV-2) vaccine.